Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2000
03/30/2000WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
03/30/2000DE19944695A1 Method for strengthening the antitumor activity of a crude drug containing polysaccharides comprises roasting the crude drug by far infrared rays followed by fermentation using microorganisms
03/30/2000CA2820588A1 Pharmaceutical composition for the treatment of acute disorders
03/30/2000CA2689373A1 G protein-coupled receptor antagonists
03/30/2000CA2345378A1 Neuroimmunophilins for selective neuronal radioprotection
03/30/2000CA2345311A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/30/2000CA2345233A1 Safe and effective biofilm inhibitory compounds and health-related uses thereof
03/30/2000CA2345232A1 Environmentally benign crop protection agents
03/30/2000CA2345111A1 Antifouling agents
03/30/2000CA2344927A1 Phosphonic acids derivatives as inhibitors of ptp-1b
03/30/2000CA2344919A1 Active enantiomer of rar.gamma.-specific agonist
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2344172A1 Antiviral combinations
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2343931A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2343321A1 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
03/30/2000CA2343193A1 Improved stereoselective process for enalapril
03/30/2000CA2343090A1 Retroviral particles protected against complement mediated destruction
03/30/2000CA2343067A1 Hairpin hybridizer molecules for modulation of gene expression
03/30/2000CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000CA2341036A1 Cyclic ester or amide derivatives
03/29/2000EP0988797A1 Compositions for postgastrectomic mineral supply
03/29/2000EP0988391A2 Recombinant adenoviral vectors comprising a splicing sequence
03/29/2000EP0988382A1 Human protein phosphatase ii-c-like protein
03/29/2000EP0988380A1 Translational regulator initiation factor 4e-binding protein
03/29/2000EP0988379A1 Ldl-receptor
03/29/2000EP0988377A1 Zinc finger protein derivatives and methods therefor
03/29/2000EP0988374A1 Hydrophilic composition containing protease produced by vibrio
03/29/2000EP0988319A1 Human l105 proteins and polynucleotides encoding same
03/29/2000EP0988316A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
03/29/2000EP0988312A1 17$g(b)-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS
03/29/2000EP0988306A1 3-substituted 3,4 dihydro-thieno 2, 3-d]pyrimidine derivatives and production and use of the same
03/29/2000EP0988304A1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
03/29/2000EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
03/29/2000EP0988301A1 Imidazolyl-cyclic acetals
03/29/2000EP0988300A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0988295A1 Heterocyclic substituted piperidines and uses thereof
03/29/2000EP0988292A2 Piperazine derivatives and their use as anti-inflammatory agents
03/29/2000EP0988285A1 Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp
03/29/2000EP0988282A2 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
03/29/2000EP0988054A1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
03/29/2000EP0988051A1 Lyme combination compositions and uses
03/29/2000EP0988048A1 Ligand/lytic peptide compositions and methods of use
03/29/2000EP0988044A1 Centipeda plant extract
03/29/2000EP0988038A1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
03/29/2000EP0988035A1 Caspases and apoptosis
03/29/2000EP0988034A1 Cox-2 selective carprofen for treating pain and inflammation in dogs
03/29/2000EP0886526A4 Protection of hemopoietic cells
03/29/2000EP0868420B1 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity
03/29/2000EP0783320A4 Protection of hemopoietic cells during chemotherapy or radiotherapy
03/29/2000EP0777689B1 Use of cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells
03/29/2000EP0739343B1 Water soluble onium salt of taxo-diterpenoid
03/29/2000EP0735868B1 Use of non-steroidal cyclooxygenase inhibitors for the manufacture of a medicament for the treatment of elevated intraocular pressure
03/29/2000EP0726763B1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
03/29/2000EP0717739B1 1,4-Benzodioxane derivatives having affinity for D2 receptors and utility in the treatment of psychoses
03/29/2000EP0602123B1 Steroid sulphatase inhibitors
03/29/2000CN1249002A Component of bromelain
03/29/2000CN1248973A Oxazolidines as 5-HT2A-antagonists
03/29/2000CN1248971A Quinoxalinediones
03/29/2000CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor
03/29/2000CN1248921A Methods of therapeutic administration of anti-CD40L compounds
03/29/2000CN1248916A Use of FXR, PPAR 'alpha' and LXR 'alpha' activators to restore barrier function, promote epidermal differentiation and inhibit proliferation
03/29/2000CN1248914A Pharmaceutical composition
03/29/2000CN1248451A Shenmei soft and hard capsule
03/29/2000CN1248439A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system
03/29/2000CN1050844C Protein kinase C inhibitors
03/29/2000CN1050841C Indole derivatives and medicinal composition having same
03/29/2000CN1050840C 咪唑脂氧合酶抑制剂 Imidazole lipoxygenase inhibitors
03/29/2000CN1050832C Process for preparing fibrinogen receptor antagonists
03/29/2000CN1050752C Instant golden tea and preparation process and use thereof
03/28/2000US6043389 Hydroxy and ether-containing oxyalkylene esters and uses thereof
03/28/2000US6043373 Heterocycle-fused thiazole derivatives
03/28/2000US6043366 Useful in treating disorders involving the orphanin fq(a seventeen amino acid long peptide) receptor.
03/28/2000US6043365 Reacting biaryl or carbocyclic or heterocyclic isopropyl nitrile derivative with a lower alkyl ester of formic acid, condensing the intermediate formed with an aminoalkyl ester to obtain intermediate, cyclizing and condensing
03/28/2000US6043343 Amino acid sequence; for diagnosis and prevention of cancer and tumors; anticarcinogenic/antitumor agents; for screening compounds which bind to polypeptide
03/28/2000US6043284 Anti-atherosclerotic diaryl compounds
03/28/2000US6043283 Administering tyramine compound to patient to inhibit injury, destruction or death of neurons
03/28/2000US6043281 Aldose reductase inhibitors; treatment or prevention of complications of diabetes
03/28/2000US6043265 Isoxazolyl endothelin antagonists
03/28/2000US6043263 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
03/28/2000US6043261 Pyrrolodino imidines useful as nitric oxide synthase inhibitors
03/28/2000US6043260 Method of treating heart failure
03/28/2000US6043259 Treatment of cardiovascular and related pathologies
03/28/2000US6043250 Treating or preventing inflammatory diseases
03/28/2000US6043249 The compounds have either a sulfhydryl moiety or are reducible disulfides; antifolates
03/28/2000US6043239 Heterocyclic compounds
03/28/2000US6043233 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
03/28/2000US6043091 Compound of 8 to 30 nucleobases targeted to coding region, 3' or 5'-untranslated region, or start codon of nucleic acid encoding a carbohydrate metabolism enzyme; for antidiabetic agents against non-insulin dependent diabetes
03/28/2000US6043069 Catalytic antibodies and a method of producing same
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6042822 Mixture of alpha-interferon-conjugate positional isomers comprises an alpha-interferon covalently conjugated to a non-antigenic alkyl terminated polyalkylene oxide at a histidine residue on alpha interferon
03/28/2000CA2198084C Novel substituted piperidines useful for the treatment of allergic diseases
03/28/2000CA2180978C Pyrrolidine-containing monomers and oligomers
03/28/2000CA2177821C Prolyl endopeptidase inhibitors
1 ... 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 ... 1564